Search

Author/Creator Ludwig, Inga

1. A framework to guide dose & regimen strategy for clinical drug development. (25th September 2021)

Authors:
Sander, Oliver; Magnusson, Baldur; Ludwig, Inga; Jullion, Astrid; Meille, Christophe; Lorand, Daniel; Bornkamp, Björn; Hinder, Markus; Kovacs, Steven J.; Looby, Michael
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 10:Number 11(2021)
Page Start:
1276
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. (May 2022)

Authors:
Bar-Or, Amit; Wiendl, Heinz; Montalban, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R; Evdoshenko, Evgeniy P; Giedraitiene, Natasa; Gross-Paju, Katrin; Haldre, Sulev; Herrman, Craig E; Izquierdo, Guillermo; Karelis, Guntis; Leutmezer, Fritz; Mares, Miroslav; Meca-Lallana, Jose ...
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 6(2022)
Page Start:
910
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗